Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Andres Alvarez, MD, PhD, EMHA
Research Director
Baptist MD Anderson Clinical Trials
Clinical Trial ID: NCT06157151
A Multicenter Phase 2 Study to Evaluate Efficacy and Safety of PRGN-2009 in Combination with Pembrolizumab in Patients with Recurrent or Metastatic Cervical Cancer.
Status
Open
Conditions
Other
Phases
2 (Cancer Control)
Age Group
Adult
Main Investiagtor
Hand, Lauren
Practice
Gyn
Scope
National
Nct ID Number
NCT06157151
Secondary Trial ID Number
PRGN-2009-201
Keywords
Treatment